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Lung interstitial ﬁbrosisLung interstitial ﬁbrosis is a chronic lung disease, and few effective therapies are available to halt or reverse the
progression of the disease. In murine and human lung ﬁbrosis, the expression of CD147 is increased. However,
the role of CD147 in lung ﬁbrosis has not been identiﬁed, and it remains to be determined whether lung ﬁbrosis
would be improved by decreasing the expression of CD147. Amurine bleomycin-induced lung interstitial ﬁbrosis
model was used in the experiments, and HAb18 mAbs and CsA were administered during the induction of lung
ﬁbrosis. In our study, we found that the HAb18 mAbs markedly reduced the collagen score and down-regulated
M1macrophages and Th17 cells. In vitro, ﬂow cytometry analysis showed that M1macrophages induced higher
Th17differentiation thanM2macrophages. After treatmentwithHAb18mAbs or after reducing the expression of
CD147 by lentivirus interference in M1 macrophages, the level of Th17 cells were signiﬁcantly inhibited. In con-
clusion, HAb18 mAbs or CsA treatment ameliorates lung interstitial ﬁbrosis. CD147 promoted M1 macrophage
and induced the differentiation of Th17 cells in lung interstitial ﬁbrosis, perhaps by regulating some cytokines
such as IL-6, IL-1β, IL-12 and IL-23. These results indicated that CD147 may play an important role in the devel-
opment of lung interstitial ﬁbrosis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Lung interstitial ﬁbrosis is a chronic lung disease that is character-
ized by the excessive accumulation of extracellular matrix (ECM),
remodeling of the lung architecture and serious complications in a vari-
ety of rheumatic autoimmune diseases. Most patients with lung in-
terstitial ﬁbrosis experience progressive respiratory failure within
3–8 years of the onset of the symptoms [1]. Few effective therapies
are available to halt or reverse the progression of this disease with a
high mortality rate. Thus, there is a large and unmet medical need for
the development of new therapeutic strategies [2].
Th17 cells, which have been reported to represent a completely dis-
tinct subset of CD4+ T cells that produce IL-17A and IL-17F and express
the IL-23 receptor (R) and retinoic acid orphan receptor (RORγt) [3],
play an important role in pulmonary ﬁbrosis [4–6]. Although theE, hematoxilin and eosin; BALF,
RORγt, retinoic acid orphan re-
s
uping@fmmu.edu.cn (P. Zhu).differentiation of Th17 cells in lung ﬁbrosis has not been reported, it
has beendescribed in autoimmune syndromes such as EAE (experimen-
tal autoimmune encephalomyelitis) and collagen-induced arthritis [7,
8]. The differentiation of Th17 cells is inﬂuenced by cytokines such as
TGF-β, IL-1β, IL-12, IL-23 [9–13]. In addition, macrophages involved in
local inﬂammation induced the differentiation of Th17 cells in response
to Th17-promoting cytokines [14,15]. Macrophages are widely distrib-
uted immune system cells [16] that can be phenotypically polarized
by themicroenvironment to mount speciﬁc functional programs. Polar-
ized macrophages can be broadly classiﬁed in two main groups: classi-
cally activated macrophages (or M1) that exhibit potent microbicidal
properties and promote strong IL-12-mediated Th1 responses [17] and
alternatively activated macrophages (or M2) that support Th2-
associated effector functions [18]. The relationship between different
types of macrophages and the differentiation of Th17 cells has not
been elucidated.
CD147 is a cell surface glycoprotein that belongs to the immunoglob-
ulin superfamily [19]. Several studies have shown that CD147 is related to
lung interstitial ﬁbrosis. For example, high levels of CD147 expression
have been found in BALF and lung tissues [20]; Betsuyaku T and Guillot
S have reported in their respective studies that lung ﬁbrosis is associated
with increased basigin/CD147 expression in mice and humans [21,22].
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interstitial ﬁbrosis. It has also been observed that in UIP-IPF (usual
interstitial pneumonia-idiopathic pulmonary ﬁbrosis) patients, CD147
expression was increased in ﬁbrotic lesions, especially in macrophages
and alveolar epithelial cells [23]. The role of CD147 on macrophages in
pulmonary ﬁbrosis has not been elucidated, and an antibody treatment
against CD147 in lung ﬁbrosis has still not been developed.
Although macrophages can induce the differentiation of Th17 cells
in local inﬂammation [24], the regulatory effect ofmacrophage subtypes
on Th17 cell differentiation in bleomycin-induced lung ﬁbrosis is not
clear. High levels of CD147 expression can be found on macrophages
[23]; however, the role of CD147 on macrophages during the disease
process remains to be investigated. In this study, we explored the
changes in lung ﬁbrosis in mice after HAb18G/CD147 mAbs treatment,
the relationship between macrophage subtypes and the differentiation
of Th17 cells in lung interstitial ﬁbrosis, and the role of CD147 during
differentiation.
2. Materials and methods
2.1. Mice
Female C57BL/6 mice were obtained from the Fourth Military Med-
ical University, Laboratory Animal Co. Ltd. All of the mice were at least
8 weeks old and weighed 18–23 g at the time of experimentation. The
animal experiments were approved by the Animal Experiment Admin-
istration Committee of the University.
The experimental mice were divided into ﬁve groups: a control
group that received a saline injection, a bleomycin group (BLM), a
bleomycin + saline group, a bleomycin + HAb18 mAbs group, and a
bleomycin + CsA group. Each group contained 36 mice.
2.2. Experimental model of bleomycin-induced lung interstitial ﬁbrosis
Lung interstitial ﬁbrosis was induced as previously described [25].
Brieﬂy, after the bodyweightwas recorded, themicewere anesthetized
via intraperitoneal injection of 30 mg/kg pentobarbital sodium. A mid-
line incision was made in the neck, and the trachea was exposed by
blunt dissection. Bleomycin hydrochloride (Nippon Kayaku, Tokyo,
Japan) was dissolved in 0.1 ml saline and injected into the animals'
lungs via 0.25 ml syringes at a dose of 7.5 mg/kg body weight. The
control group received an equal volume of sterile saline. After the
bleomycin or saline was injected into the trachea, the animal operating
platewas shaken to facilitate distribution of the solution throughout the
lungs. The day of bleomycin injectionwas considered to bed 0. Themice
were then injected with saline or 10 mg/kg HAb18 mAbs (prepared in
our laboratory) or 50 mg/kg CsA (purchased from Enzo company) be-
ginning on d 1 and then once a day at the same time point. At 4 d, 7 d,
14 d, and 28 d after bleomycin injection, three mice from each group
were sacriﬁced by cervical dislocation so that a bronchoalveolar lavage
could be performed and to collect lung samples for histologic and cellu-
lar analysis.
2.3. Histologic and immunohistochemical analysis
Mice were killed at d 4, 7, 14 or 28 following treatment with
bleomycin. The left lung was removed and ﬁxed in 10% neutral
phosphate-buffered formalin (pH 7.4). The tissues were dehydrated
gradually in ethanol, embedded in parafﬁn, cut into 4-μm sections,
stained with hematoxylin and eosin (H&E) or Masson staining, and ex-
amined by light microscopy.
Each successive ﬁeld was individually assessed for the severity of in-
terstitial ﬁbrosis using the semi-quantitative grading system described
by Ashcroft [26]. The grade of pulmonary ﬁbrosis was scored in a
blinded fashion by examining 30 randomly chosen regions per sample
at a magniﬁcation of 100×. A score ranging from 0 (normal lung) to 8(total ﬁbrosis) was assigned. The major criteria for grading pulmonary
ﬁbrosis included inﬂammatory cell inﬁltration, edema, interstitial thick-
ening of alveolar or bronchiolar walls, and collagen deposition, as fol-
lows: grade 0 = normal lung, grade 1 = minimal ﬁbrous thickening
of the alveolar or bronchial walls, grades 2–3 = moderate thickening
of walls without obvious damage to the lung architecture, grades
4–5 =increased ﬁbrosis with deﬁnite damage to the lung architec-
ture and the formation of ﬁbrous bands or small ﬁbrous masses, grades
6–7 = severe distortion of the structure and large ﬁbrous areas
(‘honeycomb lung’ was placed in this category), grade 8 = total ﬁbrous
obliteration of theﬁeld. Themean score of allﬁeldswas taken as theﬁbro-
sis score of the lung section [27].
The antibody used for immunohistochemical analyses was anti-
mouse CD147 antibody (Abcam Ltd, CA). The images from each
slide were analyzed by a pathologist blinded to the experiment. We
supposed a score ranging from 1 (normal lung) to 3 (total ﬁbrosis).
The following intensity scores were used: −, positive cell ratio b 5%,
grade 1; +, ratio of 5% to 50%, grade 2; and ++, ratio N 50%, grade 3.
The mean scores of 8 mice were taken as the score of CD147 expression
for the lung section.
2.4. Analysis of bronchoalveolar lavage ﬂuid (BALF)
Bronchoalveolar lavage (BAL) was performed by washing the lungs
three timeswith three different 1-ml aliquots of phosphate-buffered sa-
line (PBS). The BALF was centrifuged at 450 g for 10 min, the pellet was
resuspended in 100 μl PBS, and the total number of cells was counted
using a cell counting board. The number of lymphocytes, monocytes
and neutrophils were counted by Giemsa staining.
2.5. Flow cytometry (FCM)
Lung tissues frommice at d 4, 7, and 14 following the bleomycin ad-
ministration wereminced and digested with collagenase and hyaluron-
idase, respectively. After lysis of the RBCs, the dissociated cells were
underlain with 5 ml of lymphocyte separation solution (Mediatech)
and centrifuged at 2000 rpm for 20 min. The mononuclear cells in the
middle layer were collected for ﬂow cytometry. The cells homogenized
from the lungs of the mice were incubated with 1 μg/106 cells of an Fc
receptor-blocking Ab (clone 24G2; American Type Culture Collection,
Manassas, VA) and then were stained with the following 5 antibodies:
PE-conjugated anti-mouse IL-17 (Clone TC11-18H10, BD Pharmingen),
PE-conjugated anti-mouse CD206 (Clone C068SC2, Biolegend),
FITC-conjugated anti-mouse CD16/32 (Clone 2.4G2, BD Pharmingen),
APC-conjugated anti-mouse F4/80 (Clone BM8, Biolegend), and PerCP-
conjugated anti-mouse CD4 (Clone GK1.5, Biolegend). For intracellular
cytokine staining, the cells were cultured with 1 μg/ml phorbol
myﬁsmte acetate (PMA), 1 μg/ml ionomycin (Ion) and 1 μMmonensin
for 4 h, stained for surface markers and further processed using a BD
Cytoﬁx/Cytoperm and BD Perm/Wash kit (BD Biosciences, North Ryde,
New South Wales, Australia). The cells were then stained with PE-
conjugated anti-mouse CCR6 (Clone 140706, R&D), FITC-conjugated
anti-mouse IFN-γ (Clone XMG1.2, BD Pharmingen) and PerCP-
conjugated anti-mouse RORγt (Clone 600380, R&D).
Analysis was performed on a FACScan ﬂow cytometer using CellQuest
software (Becton-Dickinson).
2.6. Isolation and co-culture of CD4+ T cells and macrophage subsets
The lung tissues of mice at d 14 following bleomycin instillation
were prepared to isolate the mononuclear cells according to the above
method. For cell sorting experiments, a MoFlo (Beckman Coulter) in-
strument was used.
The M1 macrophages, deﬁned as F4/80+CD16/32+ cells [12], and
the M2 macrophages, deﬁned as F4/80+CD206+ cells [14], and CD4+
T cells were sorted by a ﬂuorescence-activated cell sorter. Then, the
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plate for 2 h. The CD4+ T cells 5 μg/ml anti-CD3 and 10 μg/ml anti-
CD28 (purchased from BD Pharmingen) were co-cultured, respectively,
with M1 macrophages or M2 macrophages in 6-well plates. Three days
later, the suspending CD4+ T cells were collected for ﬂow cytometry
analysis.B
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Fig. 1 The changes of mice instilled with bleomycin or saline. Following experiments were carri
weight of the studiedmice. Mice in the bleomycin group reached theminimum at d 14 (* = P b
cytes) in BALF. Compared with the saline group, the total cells, lymphocytes and monocytes
histopathological changes in lung tissues. In the bleomycin group, multifocal diffuse changes wer
lung tissues. E. Quantitative analysis of the ﬁbrotic grades induced by bleomycin using the Ash
F. Immunohistochemistry staining (×400) for CD147 in lung tissues. The expression of CD147 on2.7. Polymerase chain reaction (PCR) analysis
The total RNAwas isolated from themononuclear cells collected in the
lymphocyte separation solution and the puriﬁedM1, CD147-deﬁcientM1
macrophages and M2 macrophages homogenized from the lung tissues
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determined by real-time quantitative PCR using a LightCycler (Mx3005P
QPCR System) instrument and SYBR Green reagent. The expression levels
were normalized for GADPH. The following primer sequences were used:
for GADPH, 5′-TCA-ACG-GCA-CAG-TCA-AGG-3′ (forward) and 5′-ACT-
CCA-CGA-CAT-ACT-CAG-C-3′ (reverse); for iNOS, 5′-CCCTTCCGAAGTTT
CTGGCAGCAGC-3′ (forward) and 5′-CCAAAGCCACGAGGCTCTGACAGCC-
3′ (reverse); for CD86, 5′-TCAGTCAGGATGGGAGTGGTA-3′ (forward)
and 5′-ATCCAAGAGCCATTCCTACCT-3′ (reverse); for CD206, 5′CATGAG
GCTTCTCTTGCTTCTG-3′ (forward) and 5′-TTGCCGTCTGAACTGAGATGG-
3′ (reverse); for ArgI, 5′-CAGAAGAATGGAAGAGTCAG-3′ (forward) and
5′-GGTGACTCCCTGCATATCTG-3′ (reverse); for TGF-β,5′-GAT-CCC-CCT-
AGC-CTC-TCA-TC-3′(forward), and 5′-GCA-CAA-GCA-GGA-T TG-AGT-
GA-3′ (reverse); for IL-6, 5′-AGT-TGC-CTT-CTT-GGG-ACT-GA-3′(for-
ward) and 5′-CAG-AAT-TGC-CAT-TGC-ACA-AC-3′ (reverse); for IL-1β,
5′-GCG-TCC-AAA-GCA-GTT-CCC-AT T-AGA-CAA-CTG-CA-3′ (forward)
and 5′-CCG-GAA-TTC-CCA-GC C-CAT-ACT-TTA-GGA-AGA-3′ (reverse);
for IFN-γ, 5′-CAG-CTC-TT C-CTC-ATG-GCT-GTT-C-3′ (forward) and
5′-GTC-ACC-ATC-CTT-TTG-CCA-GTT-C-3′ (reverse); and for IL-4, 5′-
GCA-ACG-AAG-AAC-AC C-ACA-GAG-A-3′ (forward) and 5′-GAT-GAA-
TCC-AGG-CAT-CGA-AAA-G-3′ (reverse).
2.8. Cell culture and transduction with shRNA lentivirus vectors
The 293T cells and M1macrophages from the lungs of the mice were
cultured in Dulbecco's modiﬁed Eagle's medium supplemented with 10%
fetal calf serum (FBS). All of the recombinant lentiviruses were producedby transient transfection of 293T cells. Brieﬂy, sub-conﬂuent 293T cells
were co-transfectedwith 10 μl of liposome2000, 2.25 μg psPAX2 (packag-
ing plasmid), 0.25 μg pMD2G (envelope plasmid) and 2.5 μg of pLKO-A6
(containing CD147 shRNA insert) or 2.5 μg of pLKO-NC (empty lentiviral
vector as a control). All of the plasmids were purchased from Open
Biosystems. After 18 h, the media was changed, and the recombinant
lentivirus vectors were harvested 24 h later. For transduction, M1macro-
phages from the lungs of the mice were plated in 24-well plates (3 ×
105 cells/well), and after 24 h, media containing the recombinant lentivi-
rus vectors were added. Following 16 h of incubation, the cells were
washed and split, and puromycin was added to half of the transduced
cells at a ﬁnal concentration of 4 μg/ml. Three days later, the cells
were harvested and analyzed by Western blotting. Then, the
harvested CD147-deﬁcient M1 macrophages were prepared for the
following study.
2.9. Bio-Plex analysis of cytokines in the co-culture medium of CD4+ T cells
with M1, M2 or CD147-deﬁcient M1 macrophages
To quantify the cytokines that can induce the generation of Th17
cells in the conditioned medium of M1, M2 and CD147-deﬁcient M1
macrophages, a multiplex suspension protein array was performed
using the Bio-Plex protein array system and multiplexed (IL-6, IL-1β,
IFN-γ, IL-12, IL-23 and IL-4) bead-based immunoassay kits (Bio-Rad).
CD4+ T cells were isolated from lymphocytes and were co-cultured
with M1, M2 or CD147-deﬁcient M1 macrophages for 24 h. The media
from the co-cultured cells was collected and prepared for a multiplex
1774 J. Geng et al. / Biochimica et Biophysica Acta 1842 (2014) 1770–1782suspension protein array. A sample of 0.05% FBSmedium alonewas also
run to account for the background levels of secreted proteins. The data
were expressed as pg/ml of conditioned medium (mean ± SEM) with
an N = 3 for each group.A
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treated with HAb18G/CD147 mAbs or CsA. The body weight was maintained in mice treated
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cells, lymphocytes, andmonocytes from reduction (** = P b 0.01). C. HE staining (×400) for his
the mice treated with HAb18G/CD147mAbs or CsA. D. Masson staining (×200) for histopathol
inmice treatedwith HAb18G/CD147mAbs or CsA. E. Quantitative analysis of ﬁbrotic grades usin
in lung tissues at days 4, 7, 14, and 28. The expression of CD147 in the lung tissues of mice treat
(* = P b 0.05).2.10. Statistical analysis
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1775J. Geng et al. / Biochimica et Biophysica Acta 1842 (2014) 1770–1782analyses used were an analysis of variance (ANOVA) followed by the
appropriate post hoc tests including multiple comparison tests (LSD).
All of the analyses were made using the SPSS 11.5 statistical software
package. Differences were considered to be statistically signiﬁcant
when P b 0.05.
3. Results
3.1. The levels of bleomycin-induced lung interstitial ﬁbrosis changed at d 4,
7, 14, 28
After the instillation of bleomycin, the bodyweight of themice grad-
ually reduced and reached aminimum at d 14 (P b 0.05, comparedwith
saline group) (Fig. 1A). The BALF analysis showed that compared with
the saline group, the number of total cells, lymphocytes and monocytes
was increased in the mice that received bleomycin (P b 0.01). The
numbers of lymphocytes and monocytes increased after bleomycin in-
stillation and peaked at d 14 (P b 0.05). The total cell number decreased
gradually from d 4 to d 14 and improved slightly at d 28 (P b 0.05)
(Fig. 1B). The neutrophils gradually decreased from d 4 to d 14
(Sup. 1). HE staining and Masson staining showed that the lung tissuesections from the saline group displayed normal structure and no path-
ologic changes under a light microscope. On the 4th, 7th, 14th and 28th
day after bleomycin instillation, collagen ﬁbers and large numbers of in-
ﬂammatory cells were found, and small ﬁbrous areas emerged in the
bleomycin group mice (Fig. 1C and D). According to the Ashcroft scale,
the most serious ﬁbrosis was found at d 14 (P b 0.05, compared with
d 4) when the collagen score was 5.4 ± 0.52. The level of ﬁbrosis at d
28 (the collagen score was 3.6 ± 0.47) was less severe when compared
with d 14 (Fig. 1E). By histochemical staining, the expression of CD147
on monocytes, neutrophils and lymphocytes at d 14 was greater than
that at d 4 (P b 0.05) (Fig. 1F, Sup. 3).3.2. HAb18 mAbs or CsA treatment of lung interstitial ﬁbrosis
Treatment with HAb18 mAbs protected the mice from losing body
weight (P b 0.05, compared with bleomycin group). However, mice
treated with CsA had a greater reduction in body weight than the mice
treated with HAb18 mAbs after d 14 (P b 0.05) (Fig. 2A). BALF analysis
showed that after treatment with HAb18 mAbs or CsA, the counts of
total cells, lymphocytes, and monocytes were reduced compared
F14 d7 d
4d 7d 14d 28d
BLM
BLM+Saline
BLM+HAb18mAb
BLM+CsA
Fig. 2 (continued).
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(Fig. 2B and Sup. 1).
The histological examination and Masson trichrome staining
showed that when the bleomycin-induced mice were treated with
HAb18 mAbs or CsA, the lung tissues presented less inﬂammation
and less ﬁbrosis at d 4, 7, 14, 28 (Fig. 2C, D). Compared with the
bleomycin group, the collagen score was reduced in mice treated
with HAb18 mAbs or CsA (P b 0.05) (Fig. 2E, Sup. 2). The expression
of CD147 in the lung tissues of mice treated with HAb18 mAbs or
CsA was less than that of the bleomycin group (P b 0.05) (Fig. 2F,
Sup. 3).
3.3. Changes in the M1, M2 macrophages and Th17 cells in the lung tissues
after bleomycin instillation
M1, M2 macrophages and Th17 cells from the lung tissues of the
bleomycin-treated group at d 4, 7 and 14 were detected by ﬂow cy-
tometry and real-time PCR. Flow cytometry showed that the expres-
sion of CD16/32, CD206 and IL-17 increased gradually and peaked at
d 14 (P b 0.05) (Fig. 3A). The primary markers of M1 macrophages
(CD16/32, CD86, iNOS) and M2 macrophages (CD206, ArgI) also
increased gradually and peaked at d 14 (Fig. 3B).M1 andM2macrophages and Th17 cells from the lung tissues of the
bleomycin group and the HAb18 mAbs-treated group were also detect-
ed byﬂow cytometry and real-time PCR. At d 14, the results showed that
the levels of IL-17 in the HAb18 mAbs-treated group decreased signiﬁ-
cantly compared with the bleomycin group (2.56% ± 0.45% to 4.24% ±
0.63%, P b 0.05), and the number of CD16/32+ macrophages decreased
slightly (5.96% ± 0.35% to 7.53% ± 0.47%, P b 0.05). No obvious changes
were observed in the CD206+ M2 macrophages (8.06% ± 0.67% to
7.83% ± 0.54%) (Fig. 3C). The levels of CD16/32, CD86, and iNOS de-
creased, but no changes in CD206 or ArgI were detected after treat-
ment with HAb18 mAbs (Fig. 3D).
3.4. Macrophages induced differentiation of the Th17 cells
M1 and M2 macrophages and CD4+ T cells from lung tissues in the
bleomycin-instilled group at d 14 were sorted with a ﬂuorescence-
activated cell sorter. The M1 and M2 macrophages were co-cultured
with CD4+ T cells for three days. The control group used in this ex-
periment was CD4+ T cells cultured without macrophages. After in-
cubation, the CD4+ T cells were collected and analyzed by ﬂow
cytometry. The results showed that the expression levels of IL-17,
CCR6 and RORγt after co-culture with M1 macrophages were
AB
CD16/32
CD206
IL-17
IF
N
-¤ ¤
7d4d 14d
F4
/8
0
Fig. 3 Analysis ofM1 andM2macrophages and Th17 cells. A.M1 andM2macrophages and Th17 cells in the lung tissues of the studiedmicewere analyzed byﬂow cytometry at d 4, 7, and
14 after treatment with bleomycin. The quantity of M1 and M2 macrophages and Th17 cells increased gradually and peaked at d 14 (** = P b 0.01, * = P b 0.05). B. Real-time PCR for
CD16/32, CD86, iNOS, CD206 and ArgI in the bleomycin-treated group at d 4, 7 and 14. C. Detection of M1 and M2 macrophages and Th17 cells in ﬁbrotic lungs at d 14 after treatment
with HAb18G/CD147 mAbs. M1 macrophages and Th17 cells in the HAb18G/CD147 mAbs-treated group decreased (* = P b 0.05, compared with the bleomycin group). D. Real-time
PCR for CD16/32, CD86, iNOS, CD206 and ArgI in the bleomycin group and the HAb18G/CD147 mAbs-treated group. The following 3 groups were studied: C, control, the normal group;
B, the bleomycin treated group; and B + H, the bleomycin and HAb18G/CD147-treated group. The detection of Th17 cells was gated on CD4.
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0.32% to 1.38% ± 0.23%) and 2-fold (2.36% ± 0.46% to 0.82% ±
0.21%) higher, respectively, than the expression levels activated by
the M2 macrophages (P b 0.05) (Fig. 4A).
The total RNAwas isolated from theM1 andM2macrophages. Real-
time quantitative PCR analysis for TGF-β, IL-6, IL-1β, IFN-γ, and IL-4 re-
vealed that the levels of IL-6 and IL-1βwere higher in M1macrophages
(P b 0.01), and the levels of IFN-γ IL-4 and TGF-β were higher in M2
macrophages (P b 0.01) (Fig. 4B).
CD4+ T cells were co-culturedwithM1 orM2macrophages, and the
culturemedia was collected and subjected to cytokine analysis. The cul-
ture media in the control group was collected from CD4+ T cells that
were culturedwithoutmacrophages. TheBio-Plex suspension array sys-
tem results showed that the levels of IL-6, IL-1β, IL-23 and IL-12 in the
M1 co-culture media were higher than those in M2 co-culture media
(P b 0.05) (Fig. 4C).3.5. CD147 on M1 macrophages induced Th17 cells
Western blotting showed that compared with the control group,
the expression of CD147 on macrophages from the lungs of mice
was suppressed after transfection with shRNA lentivirus vectors
(Fig. 5A).
The levels of IL-17 in the group treated with HAb18mAbs were lower
than those in the normal M1 macrophages group (1.84% ±0.45% to
4.55% ± 0.68%, P b 0.05), and there was no difference between the
CD4+ T cells cultured in the presence or absence of the HAb18 mAbs
(Fig. 5B). When the expression of CD147 was knocked down using
shRNA lentivirus interference, the levels of Th17 cells in the CD147-
deﬁcient group were lower compared with those of the normal M1
macrophages group (2.06% ± 0.48% to 4.84% ± 0.72%, P b 0.05)
(Fig. 5C). The control group was CD4+ T cells cultured in the absence
of macrophages.
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macrophages, and the culture media was collected for cytokine
analysis. The culture media collected from CD4+ T cells cultured in
the absence of macrophages served as a control. The Bio-PlexC
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1781J. Geng et al. / Biochimica et Biophysica Acta 1842 (2014) 1770–1782The total RNA was isolated from M1 macrophages or CD147-
deﬁcientM1macrophages in the co-culture system. Real-timequantita-
tive PCR analysis for TGF-β showed that the TGF-β expression on M1
macrophages was markedly reduced when CD147 was knocked down
(P b 0.05) (Fig. 5E).
4. Discussion
In this study, we found that treatment with HAb18 mAbs or CsA
ameliorated lung interstitial ﬁbrosis, and the presence of M1 macro-
phages and Th17 cells was reduced when treated with HAb18 mAbs.
M1 macrophages had a positive effect on the differentiation of Th17
cells, and CD147 might promote this process by regulating Th17-
promoting cytokines, including TGF-β, IL-6, IL-1β, IL-12 and IL-23.
High expression levels of CD147 was found in lung ﬁbrosis, and we
also found that CD147 expression increased as the degree of pulmonary
ﬁbrosis increased in bleomycin-induced lung interstitial ﬁbrosis. To-
gether, these data indicated that CD147 might play an important role
in lung interstitial ﬁbrosis. The HAb18 mAbs block the CD147 molecule
and then inhibit the functions of CD147 [28]. CsA is an immunosuppres-
sive regimen in use for many years [29]. Both CsA and HAb18 mAbs
have an antagonistic peptide AP-9 against CD147 [30]. Therefore, we
used CsA treatment as thepositive control and contrasted itwith the an-
tibody treatment. BothHAb18mAbs and the CsA treatment ameliorated
lung interstitial ﬁbrosis. The immunohistochemical analyses showed a
gradual reduction of CD147 expression in the lung tissues when treated
with HAb18 mAbs or CsA; therefore, we hypothesized that the HAb18
mAbs or CsA might improve lung interstitial ﬁbrosis by inhibiting the
functions of CD147. However, the HAb18 mAbs seem to privilege over
CsA. For example, the body weight was conserved by treatment with
HAb18 mAbs but was reduced rapidly in mice treated with CsA; this
may have resulted from a side effect of CsA [31].
In these experiments, the most important phenomenon observed
was that the number of M1 macrophages, M2 macrophages and Th17
cells increased as the lung inﬂammationwas aggravated, and treatment
with HAb18mAbs resulted in a reduction of M1macrophages and Th17
cells at d 14. These results indicated that the presence of CD147 might
have an important role in maintaining the quantity of M1macrophages
and Th17 cells. The correlation of the changes in M1 macrophages and
Th17 cells suggested that M1 macrophages might have some relation-
ship with the Th17 cells. Therefore, we performed experiments in vitro
to search for evidence of the relationship between M1 macrophages and
Th17 cells.
In our present study, we found that of the two primary macrophage
subtypes (M1 andM2), M1macrophages induced a higher level of Th17
differentiation than theM2macrophages. The M1macrophages secrete
important cytokines, such as IL-6 and IL-1β, both of which can promote
Th17 cell differentiation [32–34]. In addition, IL-4 and IFN-γ have been
reported to be inhibitors of the differentiation of Th17 cells [36]. In our
study, we found that IL-6 and IL-1β expression levels were higher in
M1 macrophages than in M2 macrophages and that IL-4 and IFN-γ
were more highly expressed in M2 macrophages. Therefore, the M1
macrophages induced a higher level of Th17 cell differentiation than
the M2 macrophages. In addition, TGF-β, an important cytokine in
Th17 cell differentiation [35], was expressed at a higher level in M2
macrophages, which seemed to induce more Th17 cell differentiation.
However, the higher levels of IL-4 and IFN-γ in M2 macrophages may
inhibit the function of TGF-β. Although, M2 macrophages had more
TGF-β than M1 macrophages, because of the higher level of IL-4 and
IFN-γ, M2macrophages are less signiﬁcant to Th17 cells differentiation.
We assessed the role of CD147 in several in vitro experiments. The
results of ﬂow cytometry in this study showed that both M1 and M2
macrophages expressed high levels of CD147, and no signiﬁcant differ-
ence in the positive rate or the ﬂuorescence intensity was observed be-
tween the two subtypes of macrophages [Sup. 4], despite the
observation that M1 macrophages induced a higher level of Th17differentiation. How does CD147 on M1 macrophages affect the differ-
entiation of Th17 cells? Experiments in vitro indicated that CD147
might have a signiﬁcant role in the induction of Th17 cell differentiation
byM1macrophages. To deﬁne this point, we studied the effect of CD147
knock-down on related cytokines in M1macrophages. According to the
results of other studies, CD147 levels were positively correlated with
the expression of TGF-β and IL-1β [37–39]; these observations agree
with our ﬁndings.We also found that IL-6, IL-12 and IL-23were reduced
when CD147 expression was knocked down in M1 macrophages. The
presence of the cytokine IL-6 induces the expression of the IL-21 and
IL-23 receptor, which then activates the positive IL-21 autocrine regula-
tion of Th17 cell differentiation [40–42]. Thepositively regulating effects
of CD147 on IL-1β, IL-6, IL-12 and IL-23 suggested that CD147 promoted
the differentiation of Th17 cells by regulating cytokines. However, the
role of CD147 on M2 macrophages in the pathogenesis of lung ﬁbrosis
has not been explored and will be the subject of future studies.
Bleomycin-induced lung interstitial ﬁbrosis in mice has been
widely used in scientiﬁc research because its histological features
are similar to those observed in people. In recent years, this model
has made signiﬁcant contributions to the study of Th17 cells [43].
Although bleomycin-induced lung interstitial ﬁbrosis in mice is a
commonly used model, it has limitations. Bleomycin-induced lung
interstitial ﬁbrosis in mice can be reversed without any interference
[44]. This is in agreement with our observation that the symptoms
of lung ﬁbrosis improved around d 28 and showed a decrease in in-
ﬂammatory cells inﬁltration and a reduction in collagen deposition.
Because of the reversal of bleomycin-induced lung ﬁbrosis at d 28,
the data regarding M1 macrophages, M2 macrophages and Th17
cells at d 28 were not shown in this manuscript.
5. Conclusions
In summary, thedata presented in this study show thatHAb18mAbs
had a therapeutic effect on lung interstitialﬁbrosis.M1macrophages in-
duced a higher level of Th17 cell differentiation than M2 macrophages,
and CD147 promoted this progress. These results indicate that CD147
might play an important role in the process of lung interstitial ﬁbrosis,
and an antibody treatment against CD147might provide a new therapy
for the treatment of lung interstitial ﬁbrosis.
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